I just love these cash revenue guidance updates, they never fail to disappoint. The growth is almost unbelievable, but it is only the start to much bigger things. Hopefully we can dodge a takeover bid for a considerable time yet to come. Would anyone like to venture an educated guess on what the premium on the SP at that time would need to be in order for such a bid to be successful? These shares are currently tightly held, so I'd like to think that it would need to be substantial. I'm hoping to hang on to these for as long as possible.
- Forums
- ASX - By Stock
- BIG
- Ann: FY17 Cash Revenue Guidance Update
Ann: FY17 Cash Revenue Guidance Update, page-37
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online